RELATLIMAB vs REMDESIVIR: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RELATLIMAB vs REMDESIVIR: Safety Overview
| Metric | RELATLIMAB | REMDESIVIR |
|---|---|---|
| Total FAERS Reports | 177 | 10,501 |
| Deaths Reported | 29 | 2,729 |
| Death Rate | 16.4% | 26.0% |
| Hospitalizations | 145 | 2,556 |
| Average Patient Age | 64.5 yrs | 61.7 yrs |
| % Female Patients | 34.6% | 39.8% |
| FDA Approval Date | N/A | Oct 22, 2020 |
| Manufacturer | N/A | Gilead Sciences, Inc. |
| Route | N/A | INTRAVENOUS |
| Marketing Status | N/A | Prescription |